Butalbital, Acetaminophen, Caffeine And Codeine Phosphate Capsule
Product Images NDC 51991-073

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Butalbital, Acetaminophen, Caffeine And Codeine Phosphate (NDC 51991-073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 Capsule Bottle)

FDA Label Image

Chemical Structure (Butalbital 02)

FDA Label Image

Chemical Structure (Butalbital 03)

FDA Label Image

Chemical Structure (Butalbital 04)

FDA Label Image

Chemical Structure (Butalbital 05)

This is a medication guide for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules containing 50mg/325 mg/40mg/30mg per 100 capsules. This medication is prescription-only and should be taken as directed, with a maximum of 6 capsules per day. It is important to keep this medication in a tightly closed and child-resistant container, at controlled room temperature. The capsules contain FDAC Yellow No. 5 tartrazine. The medication is manufactured by LGM Pharma Solutions, LLC in Irvine, CA, and distributed by Breckenridge Pharmaceutical, Inc. in Berlin, CT.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.